Pathology after combined epicardial and endocardial ablation for ventricular tachycardia in a postmortem heart with hypertrophic cardiomyopathy.
作者信息
Nakajima Kenzaburo, Miyamoto Koji, Matsuyama Taka-Aki, Noda Takashi, Ishibashi-Ueda Hatsue, Kusano Kengo
机构信息
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Department of Pathology, National Cerebral and Cardiovascular Center, Osaka, Japan.
出版信息
HeartRhythm Case Rep. 2015 May 21;1(5):310-314. doi: 10.1016/j.hrcr.2015.04.003. eCollection 2015 Sep.
Abstract
摘要
相似文献
1
Pathology after combined epicardial and endocardial ablation for ventricular tachycardia in a postmortem heart with hypertrophic cardiomyopathy.
HeartRhythm Case Rep. 2015 May 21;1(5):310-314. doi: 10.1016/j.hrcr.2015.04.003. eCollection 2015 Sep.
2
Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation.
Heart Vessels. 2016 Aug;31(8):1337-46. doi: 10.1007/s00380-015-0732-7. Epub 2015 Aug 13.
3
Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy and Apical Aneurysm.
JACC Clin Electrophysiol. 2018 Mar;4(3):339-350. doi: 10.1016/j.jacep.2017.12.020. Epub 2018 Mar 19.
4
Prolonged high-power endocardial ablation of epicardial microreentrant VT from the LV summit in a patient with nonischemic cardiomyopathy.
HeartRhythm Case Rep. 2015 Sep 8;1(6):464-468. doi: 10.1016/j.hrcr.2015.07.008. eCollection 2015 Nov.
5
Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis.
JACC Clin Electrophysiol. 2019 Jan;5(1):13-24. doi: 10.1016/j.jacep.2018.08.010. Epub 2018 Sep 26.
6
Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
J Am Coll Cardiol. 2014 Apr 15;63(14):1416-26. doi: 10.1016/j.jacc.2013.10.087. Epub 2014 Jan 30.
7
Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
Heart Rhythm. 2013 Nov;10(11):1622-7. doi: 10.1016/j.hrthm.2013.08.021. Epub 2013 Aug 22.
8
Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility.
Heart Rhythm. 2010 Aug;7(8):1036-42. doi: 10.1016/j.hrthm.2010.05.022. Epub 2010 May 19.
9
Unipolar peak-negative voltage as an endocardial electrographic characteristic to predict overlying abnormal epicardial substrates in patients with right epicardial ventricular tachycardia.
J Cardiovasc Electrophysiol. 2014 Dec;25(12):1343-9. doi: 10.1111/jce.12495. Epub 2014 Aug 22.
10
Sinus rhythm ECG criteria associated with basal-lateral ventricular tachycardia substrate in patients with nonischemic cardiomyopathy.
J Cardiovasc Electrophysiol. 2011 Dec;22(12):1351-8. doi: 10.1111/j.1540-8167.2011.02129.x. Epub 2011 Jul 7.
本文引用的文献
1
Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia.
Circulation. 2013 Nov 19;128(21):2289-95. doi: 10.1161/CIRCULATIONAHA.113.003423. Epub 2013 Sep 13.
2
Characteristics of intramural scar in patients with nonischemic cardiomyopathy and relation to intramural ventricular arrhythmias.
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):891-7. doi: 10.1161/CIRCEP.113.000073. Epub 2013 Aug 28.
3
Real-time integration of MDCT-derived coronary anatomy and epicardial fat: impact on epicardial electroanatomic mapping and ablation for ventricular arrhythmias.
JACC Cardiovasc Imaging. 2013 Jan;6(1):42-52. doi: 10.1016/j.jcmg.2012.05.016.
4
Bipolar irrigated radiofrequency ablation: a therapeutic option for refractory intramural atrial and ventricular tachycardia circuits.
Heart Rhythm. 2012 Dec;9(12):1932-41. doi: 10.1016/j.hrthm.2012.08.001. Epub 2012 Aug 2.
5
Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy.
J Am Coll Cardiol. 2012 Jul 10;60(2):132-41. doi: 10.1016/j.jacc.2012.03.044.
6
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia.
Circulation. 2012 May 8;125(18):2184-96. doi: 10.1161/CIRCULATIONAHA.111.043216. Epub 2012 Apr 4.
7
Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update.
Circ Arrhythm Electrophysiol. 2011 Dec;4(6):889-96. doi: 10.1161/CIRCEP.111.966283. Epub 2011 Oct 7.
8
Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy.
Circ Arrhythm Electrophysiol. 2011 Apr;4(2):185-94. doi: 10.1161/CIRCEP.110.957290. Epub 2011 Jan 26.
9
Effect of epicardial fat on electroanatomical mapping and epicardial catheter ablation.
J Am Coll Cardiol. 2010 Oct 12;56(16):1320-7. doi: 10.1016/j.jacc.2010.04.054.
10
Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy.
J Cardiovasc Electrophysiol. 2011 Jan;22(1):41-8. doi: 10.1111/j.1540-8167.2010.01875.x. Epub 2010 Aug 30.
Zotero 插件